Clinical Advances in Systemic Lupus Erythematosus:
Systemic lupus erythematosus (SLE) is a complex autoimmune disease with diverse clinical presentations, providing assessment and management challenges to patients and physicians. While therapeutic advances have led to improvements in patient outcomes and survival in the past few decades, mortality and treatment adverse effects remain relatively high. Patient-clinician interaction is an integral part of managing SLE. Effective communication leads to improved care as symptoms, medications, and other aspects of the disease are addressed. This page provides education on the assessment, management, and treatment of SLE.
Developed through a partnership between Medscape and the Lupus Foundation of America with an independent educational grant from GlaxoSmithKline
Steering Committee Chair
Professor of Medicine
Director
Hopkins Lupus Center
Johns Hopkins University
Baltimore, Maryland
Chief, Division of Rheumatology
Northwell Health
Professor of Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Hempstead, New York
Professor of Medicine
Allegheny Health Network
Temple University School of Medicine
Pittsburgh, Pennsylvania
Director of Clinical Projects
Arthritis & Clinical Immunology Program
Oklahoma Medical Research Foundation
OMRF Professor of Medicine
Department of Rheumatology and Immunology
Adjunct Professor, School of Pharmacy
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
Professor of Medicine
Cedars-Sinai Medical Center
David Geffen School of Medicine
University of California, Los Angeles
Associate Director, Rheumatology Fellowship Program
Board of Governors
Cedars-Sinai Medical Center
Los Angeles, California
Professor
University of Pennsylvania
Philadelphia, Pennsylvania